back to

Back to video list

Audience Q&A

Session

Bridging the gap between efficacy and toxicity in the frontline treatment of stage IV Hodgkin lymphoma

Others Talks of this Session

Welcome and introduction
Hot off the press: The latest data for the frontline treatment of patients with Stage IV CD30+ Hodgkin Lymphoma from ECHELON-1
Bridging the gap: Balancing efficacy and toxicity in three challenging case studies (A debate and audience discussion with our panel)